SCHEMBL19230648

SCHEMBL19230648

COC(=O)c1ccc2c(c1)OCC(c1ccc(O)cc1Cl)O2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.42
NPC1 O15118 6/20 0.42
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
TSHR P16473 3/20 0.41
KDM4E B2RXH2 3/20 0.41
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
MAPT P10636 4/20 0.39
HSD17B10 Q99714 2/20 0.39
ALOX15 P16050 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
NISCH Q9Y2I1 1/20 0.37
POLB P06746 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19230647 0.83 RAB9A (0.43) RAB9AMEN1KMT2AMAPTCA12
SCHEMBL19230805 0.81 ESR1 (0.49) RAB9AMEN1KMT2ASMN1; SMN2TSHR
SCHEMBL19230310 0.81 ESR1 (0.49) RAB9AMEN1KMT2ASMN1; SMN2TSHR
SCHEMBL19230656 0.81 ESR1 (0.49) RAB9AMEN1KMT2ASMN1; SMN2TSHR
SCHEMBL19230672 0.81 ESR2 (0.46) MEN1KMT2ACA12CA1CA2
SCHEMBL19230649 0.79 NPC1 (0.37) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL23800712 0.73 NPC1 (0.48) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL16372412 0.71 MTNR1A (0.46) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL19230591 0.70 DRD2 (0.43) SMN1; SMN2TSHRKDM4ECA12CA1
SCHEMBL18397240 0.70 CSF1R (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602811-B FXR receptor agonists 轩竹生物科技有限公司 2021-11-16 CN disclosed
WO-2017133521-A1 FXR RECEPTOR AGONIST 山东轩竹医药科技有限公司 2017-08-10 WO disclosed